ORIC Pharmaceuticals

Filed a patent for "prc2 inhibitors for use in treating sickle cell disease" on Thu, August 24, 2023

Filed a patent for "treatment of prostate cancer" on Fri, August 4, 2023

Filed a patent for "treatment of prostate cancer" on Tue, November 28, 2023

Filed a patent for "treatment of prostate cancer" on Fri, January 5, 2024

Filed a patent for "cd73 inhibitors" on Thu, January 30, 2025

Filed a patent for "treatment of neuroendocrine prostate cancer" on Tue, January 3, 2023

Filed a patent for "treatment of t-cell lymphoma" on Tue, April 11, 2023

Filed a patent for "methods of treating cancers comprising atypical egfr mutations" on Fri, May 5, 2023

Filed a patent for "treatment of prostate cancer having androgen receptor variants" on Wed, May 10, 2023

Filed a patent for "treatment of neuroendocrine prostate cancer" on Tue, August 8, 2023

Filed a patent for "methods of treating cancers comprising atypical egfr mutations" on Thu, October 19, 2023

Filed a patent for "inhibitors of epidermal growth factor receptor" on Tue, April 23, 2024

Filed a patent for "malonate and glycolate salts of an egfr inhibitor" on Thu, November 3, 2022

Filed a patent for "polo like kinase 4 inhibitors" on Tue, November 15, 2022

Filed a patent for "uses of glucocorticoid receptor (gr) antagonist and androgen receptor (ar) degrader combinations" on Thu, September 28, 2023

Filed a patent for "pharmaceutical forms of a cd73 inhibitor" on Thu, April 20, 2023

Filed a patent for "polo like kinase 4 inhibitors" on Thu, November 16, 2023

Filed a patent for "malonate and glycolate salts of an egfr inhibitor" on Thu, May 4, 2023

Filed a patent for "polo like kinase 4 inhibitors" on Thu, April 18, 2024

Filed a patent for "cd73 inhibitors" on Thu, April 18, 2024

Filed a patent for "malonate and glycolate salts of an egfr inhibitor" on Thu, October 19, 2023

Filed a patent for "polo like kinase 4 inhibitors" on Thu, August 15, 2024

Filed a patent for "prc2 inhibitors for use in treating blood disorders" on Thu, March 21, 2024

Filed a patent for "polo like kinase 4 inhibitors" on Mon, October 3, 2022

Filed a patent for "physical forms of an inhibitor of prc2" on Wed, September 14, 2022